Get started
Author

Catherine J. Stansfield

Observed names: C Stansfield, C. Stansfield, Catherine Stansfield
ORCID: 0000-0002-7775-2337
Observed ORCID: 0000-0002-7775-2337
OpenAlex ID: A5103174030
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
2020 · Nicholas A Kennedy, Gareth-Rhys Jones, et al. · Gut · 257
PDF
Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients
2020 · Kevin Whelan, Trevor Murrells, et al. · American Journal of Clinical Nutrition · 75
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
2018 · Marco Vincenzo Lenti, Scott Levison, et al. · Digestive and Liver Disease · 58
PDF
A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II
2021 · Marco Vincenzo Lenti, Vivien Dolby, et al. · Alimentary Pharmacology & Therapeutics · 40
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
2021 · Shaji Sebastian, Gareth J Walker, et al. · The Lancet. Gastroenterology & hepatology · 38
PDF
Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK
2021 · JR Fraser Cummings, Aileen Fraser, et al. · BMJ Open Gastroenterology · 14
PDF
288 Anti-TNF Withdrawal in IBD: Relapse and Recapture Rates and Predictive Factors From 160 Patients in a Pan-UK Study
2015 · Nicholas A. Kennedy, Benjamin D. Warner, et al. · Gastroenterology · 6
Disease Recurrence and Long-term Outcomes Following the Development of Intestinal Failure in Crohn’s Disease: Over 20 Years of Experience from a National Reference Centre
2023 · Maja Kopczynska, Benjamin Crooks, et al. · Journal of Crohn s and Colitis · 5
PDF
Implementation of an IBD nurse−led self−management programme
2008 · Catherine Stansfield, Andrew Robinson · Gastrointestinal Nursing · 5
PTU-081 The impact of a nurse co-ordinated ibd multidisciplinary team meeting in enhancing safety and reducing cost
2015 · C Stansfield, A Robinson, et al. · Gut · 3
PWE-013 Feraccru® real world effectiveness study in hospital practice (fresh): an interim analysis
2018 · Fraser Cummings, Catherine Singfield, et al. · Gut · 2
PDF
P525 Effectiveness and safety of vedolizumab in IBD patients: a multicentre experience of “real world data” from the UK
2017 · M.V. Lenti, S. Levison, et al. · Journal of Crohn s and Colitis · 2
Inflammatory bowel disease: current challenges and advances in treatment
2016 · Catherine Stansfield · British Journal of Healthcare Management · 2
Tu1092 The Impact of a Nurse Co-Ordinated IBD Multidisciplinary Team Meeting in Enhancing Safety and Reducing Cost
2015 · Catherine J. Stansfield, Simon Lal, et al. · Gastroenterology · 2
OC-082 The Development of a Web-Based System to Enhance Care in Inflammatory Bowel Disease
2013 · C R Calvert, S Lal, et al. · Gut · 2
PDF
Disease recurrence and long-term outcomes following the development of intestinal failure in Crohn’s disease: A 20-year experience from a national reference centre
2023 · M. Kopczynska, B. Crooks, et al. · Clinical Nutrition ESPEN · 1
PDF
P128 Outcomes of ustekinumab in Crohn’s Disease: the real-world experience of a tertiary ibd centre
2021 · Bethany Miller, Catherine Stansfield, et al. · Gut · 1
PDF
OC-052 5 year follow up of a nurse led guided self management programme in ibd
2015 · C Stansfield, A Robinson, et al. · Gut · 1
Tu1093 5 Year Follow up of a Nurse Led Guided Self Management Programme in IBD
2015 · Catherine J. Stansfield, Robinson Andrew, et al. · Gastroenterology · 1
Risk assessment for new therapies in inflammatory bowel disease
2010 · Catherine Stansfield · Nurse Prescribing · 1
Loss of Response to Anti‐Tumor Necrosis Factor Alpha Therapy in Patients With Inflammatory Bowel Disease: A Real‐World Comparison of Combination Therapy Versus Monotherapy
2026 · Faris Chater, Maja Kopczynska, et al. · JGH Open
Maintaining an IBD Nurse Service
2025 · Catherine Stansfield · Springer eBooks
Commentary: The impact of Inflammatory Bowel Disease related fatigue on Health-Related Quality of Life: a qualitative semi-structured interview study
2021 · Catherine Stansfield · Journal of research in nursing
P352 A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn’s disease. The Cross Pennine study II
2021 · M V Lenti, V Dolby, et al. · Journal of Crohn s and Colitis
P147 Safety and efficacy of ustekinumab for Crohn’s disease (CD): the cross pennine experience
2021 · Vivien Dolby, Tanya Clark, et al. · Gut
Works count: 38
Citation count: 516
H-index: 6
I10-index: 6
Year
Topic
Type